Wyeth Normiflo low molecular weight heparin approved by FDA May 23.
Executive Summary
WYETH-AYERST NORMIFLO LOW MOLECULAR WEIGHT HEPARIN CLEARS FDA May 23 for prevention of deep vein thrombosis in knee replacement surgery patients. Normiflo (aldeparin) will be the third low molecular weight heparin on the market. Rhone-Poulenc Rorer markets Lovenox for hip and knee replacement procedures and recently received clearance for use of the product in abdominal surgery ("The Pink Sheet" May 19, T&G-6). Pharmacia & Upjohn markets Fragmin for abdominal surgery and has filed for hip replacement.